Sterile Filtration Market

Global Sterile Filtration Market Size (2022 to 2027)

As per our latest research report, the global sterile filtration market is expected to grow by USD 6.41 billion in 2022 and is estimated to grow at a CAGR of 12.5% and worth USD 11.56 billion by 2027.

Filtration makes the products purified adequately and suitable for consumption, helps optimize process economics, and avoids the loss of valuable products. Therefore, it is an essential operation in the pharmaceutical industry. Fluids such as drug products damaged by heat, chemical sterilization, or irradiation can be sterilized by microfiltration using different membrane filters. This method is commonly used for protein solutions in medical drug processing and labile pharmaceuticals.

Impact of COVID-19 on the global sterile filtration market:

COVID-19 is an infectious disease that is caused by a recent novel coronavirus. The sudden outbreak of pandemics has kept many lives at risk. The economy has been severely affected by the pandemic.  The global economy and the market were adversely affected; the market structure has been completely changed. Manufacturers are making changes according to the changing needs of the people.

COVID-19 has favored the sterile filtration market and accelerated its growth rate. Countries are in a global run to expand and produce a vaccine for the SARS-COV-2. Government bodies are increasing funding for vaccine development, and various filtration techniques are being used to develop and produce vaccines. Researchers are working on testing a wide variety of potential COVID-19 treatments. Antibodies treatments are being explored, tamping the body’s immune response when it becomes destructive, resulting in critical COVID-19 patients. Pharmaceutical companies have increased the production of these drugs because of the increased demand.

Using sterile techniques, microorganisms can be removed during the upstream and downstream drug development, and final drug sterility can be assured using absolute drug sterility. Therefore, mass production of these drugs increases sterile processes, which is more likely to boost the market growth. As a result, the market is projected to have a better share during the forecast period.

MARKET DRIVERS:

The growing biopharmaceutical industry strongly drives the growth of the global sterile filtration market. In addition, an increase in the R&D spending, growing production of large molecules and biologics, the rise of the generic drugs market, rising incidence of diabetes & kidney failure, increasing demand for biopharmaceutical molecules, and increasing purity requirement in the end-user market are further propelling the sterile filtration market.

Sterile filtration is an essential application in the biopharmaceutical industry to develop quality products, which is anticipated to boost the sterile filtration market in the future.

The rise in support from private and public organizations through investments in pharmaceutical industries creates chances for the market to grow. Besides, the emergence of Nano filters for removing microorganisms is accelerating the demand for the sterile filtration market. Increasing incidences of various health disorders due to lifestyle changes are also expected to accelerate the market's growth. Adopting the latest technologies and launching innovative products in favor of the end-users will surge growth opportunities for the market. 

Increased pharmaceutical investment and the high prevalence of chronic and acute diseases are other significant factors driving the growth of the sterile filtration market.

According to data from the Organization for Economic Cooperation and Development (OECD), in 2013, pharmaceutical investment in OECD countries was approximately $ 800 billion, accounting for about 20% of total healthcare investment. Also, the high demand for medicines and the introduction of new drugs are the key factors leading to increased investment in the pharmaceutical industry. According to the same source, the number of people using antidiabetics, antidepressants, and antihypertensive drugs tripled, and the number of people using cholesterol-lowering drugs tripled between 2000 and 2013. These trends reflect the growing demand for sterile filtration of drugs.

Moreover, several chronic diseases such as cancer, diabetes, and mental illness have increased medical care demand. For instance, according to the British "Cancer Research" report, the country registered 55.122 new breast cancer cases in 2015. Also, there is an increase in diagnosis, identification of diseases, early treatment of drugs, and the development of new medicines. In addition, the treatment of common diseases leads to increased drug consumption.

MARKET RESTRAINTS:

However, stringent government regulations for validating the filtration process are the major factors restraining the growth of the global sterile filtration market.

REPORT COVERAGE:

This research report on the global sterile filtration market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2027.

Sterile Filtration Market – By Product:

• Membrane Filters
  • MCR
  • Coated Cellulose Acetate
  • PTFE
  • PVDF
  • PES
  • Nylon Filter Membranes
• Bottle-Top Vacuum Filters
• Cartridges & Capsules
• Syringe Filters
• Filtration Accessories
• Filter Holders

In the product segment, the membrane filters segment dominated the global sterile filtration market in 2021. Increasing sterile filtration applications in pharmaceutical and biopharmaceutical laboratories are lavishing the market's growth. In addition, a growing number of patients with kidney failure issues globally is fuelling the market's growth to the extent.

Sterile Filtration Market – By Application:

• Bioprocesses
• Cell Culture Growth Media
• Fill-finish process
• Virus filtration
• Utility Filtration
• Pre-Filtration

Based on the application, the bioprocess segment held the largest share in the global sterile filtration market in 2021 due to the increasing demand to produce large molecules and biologics, increasing awareness of the process in almost every end-user industry.

Sterile Filtration Market – By Membrane Pore Size:

• 0.22 microns
• 0.45 microns
• 0.1 microns

Based on the membrane pore size, the 0.22 microns segment is estimated to lead the global sterile filtration market from 2022 to 2027. Increasing demand to effectively remove the microorganisms from the fluids used in the manufacturing of drugs is leveraging the market demand.

Sterile Filtration Market – By End-user:

• Pharmaceutical & biotechnology companies
• Food & beverage industry
• Academic institutes & research laboratories
• Water filtration companies

Based on the end-user, the pharmaceutical and biotechnology companies segment led the sterile filtration market in 2021. Increasing the scale of pharmaceutical companies is one factor elevating the growth rate of the sterile filtration market.

Sterile Filtration Market – By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Geographically, the North America sterile filtration market accounted for the largest share of the global market in 2021. The presence of several pharmaceutical, biotechnology, and food and beverage players in North America, the existence of a well-established healthcare sector, and strict laws for the pharmaceutical industry are majorly favoring North America to register the domination in the global market. In addition, the rise in the number of Active Pharmaceutical Ingredients (API) production facilities using syringe filters and the increase in the investments in R&D activities in the North American region are further boosting the market growth in this region. The U.S. Food and Drug Administration (FDA) and the U.S. Pharmacopoeia (USP) define sterile filtration as producing sterile effluent with nominal ratings of 0.22 m and 0.2 m, respectively. The acquisition of RIS Facility Management GmbH was announced by American Air Filter Company, Inc. and its affiliate, AAF Lufttechnik GmbH. The acquisition's goal is to increase the operations and global reach of American Air Filter Company, Inc.

Over the forecast period, the Asia–Pacific sterile filtration market is anticipated to have the quickest CAGR. Growth in this market can be attributed to the increase in R&D spending, rising prevalence of chronic kidney disease (CKD) and kidney failure, and development of new biologics and growing pharmaceutical research. The market for generic drugs and biosimilars is on the rise, and biopharmaceutical companies have made large expenditures. The desire for affordable drugs and the growing focus on sterile filtration devices such as syringe filters in healthcare modernization are driving the growth of the sterile filtration market in the Asia-Pacific region. A sizable and expanding industrial base has resulted from the recent exponential economic rise of nations such as China and India. This is also credited to trade liberalization and structural reforms focusing on the market, which has accelerated economic growth in many countries. As a result, global firms in the pharmaceutical sector are choosing emerging economies as their preferred locations for manufacturing and research, and these regions are now known as pharmerging markets.

The sterile filtration market in Europe is anticipated to expand significantly because of regulatory requirements for cleanrooms in pharmaceutical production, technological advancements in nanofibers, rising production of large molecules and biologics, and growth in the generics market, and technological advances in large molecules and biologics. Due to the introduction of various pharmaceutical companies to meet domestic export and import demands, which supports regional growth, Germany is also anticipated to have the fastest growth rate in this region.

The Latin American sterile filtration market is expected to grow at a CAGR of 8.98% from 2022 to 2027.

The sterile filtration market in MEA is forecasted to value USD 710 million by 2027.

KEY MARKET PARTICIPANTS AND SHARE INSIGHTS:

Some noteworthy companies dominating the global sterile filtration market profiled in the report are Merck & Co Inc., 3M, General Electric Company, Pall Corporation, Parker Hannifin Corporation, Sartorius Stedim Biotech Group, Porvair Filtration Group, Sterlitech Corporation, and Starlab Scientific Co., Ltd.

Leading companies offer a wide range of products and continue to expand their existing product portfolio. Most of these participants have an enhanced distribution network in a wide geographical area. Secure distribution channels, a vast product portfolio, and the launch of new products have led to fierce competition among suppliers. It puts tremendous pressure on pricing strategies and affects supplier margins. Leading players participate in collaboration, new product development, mergers and acquisitions, and regional expansion to gain a larger share in the global sterile filtration market. Mergers and acquisitions help companies increase their existing product portfolio and geographic reach. In August 2015, Danaher completed Pall's acquisition and entered the field of filtration, separation, and purification solutions.